Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More

Seeking Alpha11/18 13:09

オラジェニクス | 10-Q：Q3 2024 四半期報告書

SEC11/14 03:43

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

GlobeNewswire10/18 20:30

Oragenics Shares Are Trading Higher After the Company Provided a Corporate Update on Its 2024 Progress Including Developments of ONP-002, Its Lead Candidate for Concussions.

Benzinga10/09 21:14

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

Oragenics10/09 12:00

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

GlobeNewswire10/08 20:45